| Cvs Pharmacy #01461 | |
| 15600 Columbia Pike, Burtonsville, Maryland 20866 | |
| (301) 421-9060 |
| Name | Cvs Pharmacy #01461 |
|---|---|
| Organization Name | Maryland Cvs Pharmacy Llc. |
| Location | 15600 Columbia Pike, Burtonsville, Maryland 20866 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (301) 421-9060 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for drug dependence, smoking cessation and obesity, announced today that the company has retained Exponential Pharma Ventures LLC to assist in establishing a clinical development partnership for its cocaine dependence program with a fully integrated pharmaceutical company.
Patients with stage III colon cancer who have undergone surgery and chemotherapy with the goal of cure may have a higher risk of relapsing and dying early if they follow a predominantly Western diet of red meat, fatty foods, refined grains, and desserts, according to research led by investigators at Dana-Farber Cancer Institute in Boston.
The ORBERA Managed Weight Loss System received its final approval on Wednesday, August 5th and Ultimate Bariatrics is proud to be one of the first in the country to offer this new tool in helping people achieve their weight loss goals. Ultimate Bariatrics is excited to share that the U.S. Food and Drug Administration has approved ORBERA, a safe and effective weight loss solution with 20 years of global experience and real world results.
Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer Research Centre, have published in Cancer Cell the results of a study that shows full regression of advanced pancreatic ductal adenocarcinoma upon combined inhibition of the epidermal growth factor receptor and c-RAF kinase.
› Verified 1 days ago
| NPI Number | 1396849220 |
| Organization Name | MARYLAND CVS PHARMACY, L.L.C. |
| Doing Business As | CVS PHARMACY # 01461 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 15600 Columbia Pike, Burtonsville, MD 20866 |
| Phone Number | 301-421-9060 |
News Archive
Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for drug dependence, smoking cessation and obesity, announced today that the company has retained Exponential Pharma Ventures LLC to assist in establishing a clinical development partnership for its cocaine dependence program with a fully integrated pharmaceutical company.
Patients with stage III colon cancer who have undergone surgery and chemotherapy with the goal of cure may have a higher risk of relapsing and dying early if they follow a predominantly Western diet of red meat, fatty foods, refined grains, and desserts, according to research led by investigators at Dana-Farber Cancer Institute in Boston.
The ORBERA Managed Weight Loss System received its final approval on Wednesday, August 5th and Ultimate Bariatrics is proud to be one of the first in the country to offer this new tool in helping people achieve their weight loss goals. Ultimate Bariatrics is excited to share that the U.S. Food and Drug Administration has approved ORBERA, a safe and effective weight loss solution with 20 years of global experience and real world results.
Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer Research Centre, have published in Cancer Cell the results of a study that shows full regression of advanced pancreatic ductal adenocarcinoma upon combined inhibition of the epidermal growth factor receptor and c-RAF kinase.
› Verified 1 days ago
News Archive
Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for drug dependence, smoking cessation and obesity, announced today that the company has retained Exponential Pharma Ventures LLC to assist in establishing a clinical development partnership for its cocaine dependence program with a fully integrated pharmaceutical company.
Patients with stage III colon cancer who have undergone surgery and chemotherapy with the goal of cure may have a higher risk of relapsing and dying early if they follow a predominantly Western diet of red meat, fatty foods, refined grains, and desserts, according to research led by investigators at Dana-Farber Cancer Institute in Boston.
The ORBERA Managed Weight Loss System received its final approval on Wednesday, August 5th and Ultimate Bariatrics is proud to be one of the first in the country to offer this new tool in helping people achieve their weight loss goals. Ultimate Bariatrics is excited to share that the U.S. Food and Drug Administration has approved ORBERA, a safe and effective weight loss solution with 20 years of global experience and real world results.
Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer Research Centre, have published in Cancer Cell the results of a study that shows full regression of advanced pancreatic ductal adenocarcinoma upon combined inhibition of the epidermal growth factor receptor and c-RAF kinase.
› Verified 1 days ago
Giant Pharmacy #2301 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 15618 Old Columbia Pike, Burtonsville, Maryland 20866 Phone: (301) 421-4493 | |
Cvs Pharmacy #01461 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 15600 Columbia Pike, Burtonsville, Maryland 20866 Phone: (301) 421-9060 |